Stockhub

ReNeuron Group plc: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

4 September 2022

  • curprev 10:5910:59, 4 September 2022 >Nick 993 bytes +993 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == ReNeuron Group plc researches, develops, and commercializes cell-based therapies in the United Kingdom. The company engages in the development of CTX stem cell therapy candidate that is in the partnering stage in china and outside china for treating stroke disability; and human retinal progenitor cell therapy that is in Phase I/IIa clinical trial for treating retinitis pigmentosa, a blindness-causing disease. It also develo..."
Retrieved from "https://stockhub.co/research/ReNeuron_Group_plc"